Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...

The guidelines are a first-of-its-kind effort to establish recommendations for the medical management of HS in seven ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

President Trump has vowed to impose tariffs on China, Mexico, and Canada. They could make common medicines less affordable.

The stock has spent the past few years in the shadow of a COVID-19 boost, but it's time investors see the light.

Mr Bourla does not say in the interview that COVID jabs are dangerous. The interview begins at the 35 seconds mark of the ...

However, Pfizer's revenue guidance for 2025 doesn't look particularly exciting. The company expects its top line to come in ...

The general mood among these heavyweight investors is divided, with 33% leaning bullish and 50% bearish. Among these notable ...

Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...

Pfizer Inc. ( NYSE:PFE ) will increase its dividend from last year's comparable payment on the 7th of March to ...

In 2024, companies in the broader market that paid dividends returned around 35% of their net income and 45% of their free ...

Here are three dividend stocks that retirees can buy with confidence as they offer recurring, dependable payouts and a degree ...